TB Dispensary Arkhangelsk, Northern Russia
In Russia, MSF is collaborating with health authorities and academic partners in Arkhangelsk region to reduce the burden of drug-resistant tuberculosis and improve treatment for the disease.

In 2019, our teams in Arkhangelsk region began providing drugs and technical advice to support the treatment of patients with the most severe forms of TB in line with the latest World Health Organization recommendations. We are currently supporting the treatment of dozens of patients.

In partnership with Arkhangelsk Regional Ministry of Health, Northern State Medical University and Arkhangelsk Clinical TB Dispensary, we are building on existing expertise and working together to implement new all-oral short-course regimens. The aim of the collaboration is to provide evidence for future developments in TB policy in Russia and increase the availability of more effective models of treatment.  

MSF teams are also responding to the COVID-19 pandemic.

Our teams have been working in Russia since the early 1990s, running programmes in Moscow, Saint Petersburg, Kemerovo region, Chechnya, Ingushetia and Dagestan. 

Tuberculosis treatments yield promising results in the Chechen Republic

Tuberculosis treatments yield promising results in the Chechen Republic

Voices from the Field 10 Nov 2017

MSF closes mental health programme in Ingushetia

Project Update 23 Nov 2012

Emergency response to people affected by wood fires in Russia

Project Update 12 Aug 2010

Hope for peace in Ingushetia has given way to despair

Project Update 29 Sep 2009

Geneva court rules in favour of MSF in Dutch government case

Press Release 27 Feb 2008

MSF's mental health program in Ingushetia and Chechnya

Project Update 28 Jun 2006

Contact us

TB treatments yield promising results in the Chechen Republic
MSF Moscow

16 Malaya Dmitrovka street,
127006 Moscow,
Russian Federation